Form 4 for BCRX BIOCRYST PHARMACEUTICALS INC
Accepted 2025-12-23 00:00:00 ET · period of report 2025-12-19 · accession 0000882796-25-000043 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-23 | 2025-12-19 | BCRX | Barnes Alane P | CLO | F - Tax | $7.41 | -16.9K | 420.5K | -4% | -$125.2K | |
| 2025-12-23 | 2025-12-22 | BCRX | Barnes Alane P | CLO | S - Sale | $7.65 | -21.8K | 398.8K | -5% | -$166.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-19 | F | D | 16,902 | $7.41 | 420,524 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted restricted stock units. This transaction does not represent a sale by the reporting person. |
| 2 | Common | Common Stock | 2025-12-22 | S | D | 21,773 | $7.65 | 398,751 | D | — | — | (F2) This transaction was made pursuant to a plan adopted by the reporting person on August 13, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person. |